<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape HIV/AIDS Headlines</title>
		<link>http://www.medscape.com/hiv?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape HIV/AIDS</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape HIV/AIDS Headlines</title>
			<link>http://www.medscape.com/hiv?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Thu, 24 Jul 2008 22:05:00 EDT</pubDate>
		<managingEditor>hiveditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>U.S. Government to Release Revised U.S. HIV Estimates</title>
			<link>http://www.medscape.com/viewarticle/577943?src=rss</link>
			<description>The U.S. Centers for Disease Control and Prevention said on Tuesday it will soon release long-awaited revised estimates of how many Americans become infected with the AIDS virus every year.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Wed, 23 Jul 2008 23:37:53 EDT</pubDate>
		</item>
		<item>
			<title>HIV-1 Integrase Inhibitor Effective for Resistant HIV-1</title>
			<link>http://www.medscape.com/viewarticle/577958?src=rss</link>
			<description>In combination with an optimized background regimen, the HIV-1 integrase inhibitor raltegravir (Isentress) is an effective treatment for HIV infection with triple-class drug resistance, new research shows.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Thu, 24 Jul 2008 09:58:46 EDT</pubDate>
		</item>
		<item>
			<title>High-Dose Immunochemotherapy Safe for HIV-Infected Adults With Burkitt Lymphoma</title>
			<link>http://www.medscape.com/viewarticle/577961?src=rss</link>
			<description>High-dose immunochemotherapy can safely be administered to HIV-infected patients with adult Burkitt lymphoma, according to a report in the July 1st Cancer.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 24 Jul 2008 10:03:26 EDT</pubDate>
		</item>
		<item>
			<title>Novel Vaccine Boosts Survival in Glioblastoma Patients</title>
			<link>http://www.medscape.com/viewarticle/577844?src=rss</link>
			<description>A dendritic cell vaccine significantly increased time to survival and time to tumor progression in glioblastoma patients, and a correlation was shown between cancer clinical outcome and T cell responsiveness after therapeutic vaccination.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Tue, 22 Jul 2008 09:12:00 EDT</pubDate>
		</item>
		<item>
			<title>Maximizing HAART Coverage Has Potential to Curb HIV Epidemic</title>
			<link>http://www.medscape.com/viewarticle/577852?src=rss</link>
			<description>Treatment of at least 75% of individuals who are eligible for treatment of human immunodeficiency virus (HIV) infection with highly active antiretroviral therapy (HAART) has the potential to &quot;curb the growth of the HIV epidemic,&quot; Canadian researchers announce.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Infectious Diseases</category>
					<pubDate>Tue, 22 Jul 2008 23:39:41 EDT</pubDate>
		</item>
		<item>
			<title>Omeprazole Boosts Saquinavir Exposure in HIV Patients</title>
			<link>http://www.medscape.com/viewarticle/577885?src=rss</link>
			<description>In HIV patients taking saquinavir/ritonavir, use of omeprazole leads to a significant - and apparently well tolerated - increase in saquinavir plasma exposure.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Tue, 22 Jul 2008 23:48:46 EDT</pubDate>
		</item>
		<item>
			<title>Physicians for Sale: How Medical Professional Organizations Exploit Their Members</title>
			<link>http://www.medscape.com/viewarticle/577178?src=rss</link>
			<description>To improve the state of US healthcare, physicians need to rethink what their profession is and identify what they need to do to regain their professional integrity. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Mon, 21 Jul 2008 08:50:07 EDT</pubDate>
		</item>
		<item>
			<title>Building Physician Connectivity for e-Prescribing</title>
			<link>http://www.medscape.com/viewarticle/577274?src=rss</link>
			<description>Kevin Hutchinson, President and Chief Executive Officer of Prematics, Inc., in Vienna, Virginia, tells us how to move e-prescribing forward. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 18 Jul 2008 08:53:10 EDT</pubDate>
		</item>
		<item>
			<title>HIV Vaccine Trial Cancelled</title>
			<link>http://www.medscape.com/viewarticle/577773?src=rss</link>
			<description>The National Institute of Allergy and Infectious Diseases has decided not to move forward with the PAVE 100 HIV vaccine trial because it says the vaccine regimen does not warrant a large trial at this time.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Fri, 18 Jul 2008 21:51:03 EDT</pubDate>
		</item>
		<item>
			<title>Senate Votes to Repeal Ban on HIV-Infected Visitors and Immigrants</title>
			<link>http://www.medscape.com/viewarticle/577772?src=rss</link>
			<description>The U.S. Senate voted on Wednesday to repeal the law barring HIV-infected visitors and immigrants from the country, an action applauded by numerous human rights organizations.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Sun, 20 Jul 2008 21:56:36 EDT</pubDate>
		</item>
		<item>
			<title>FDA Approvals: Aciphex, Durezol, Aptivus</title>
			<link>http://www.medscape.com/viewarticle/577660?src=rss</link>
			<description>The FDA has approved an expanded indication for rabeprazole tablets, difluprednate ophthalmic emulsion, and an oral solution formulation plus pediatric dosing recommendations for tipranavir.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Thu, 17 Jul 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>U.S. Senate Passes Bill to Boost Global AIDS Funds</title>
			<link>http://www.medscape.com/viewarticle/577676?src=rss</link>
			<description>The U.S. Senate, fending off opposition from some conservative Republicans, voted on Wednesday to spend $48 billion to fight AIDS worldwide over the next five years.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Thu, 17 Jul 2008 18:42:10 EDT</pubDate>
		</item>
		<item>
			<title>Boosted HIV Protease Inhibitor Regimen Does Not Raise Drug Concentrations</title>
			<link>http://www.medscape.com/viewarticle/577649?src=rss</link>
			<description>Contrary to previous reports, use of lopinavir-ritonavir along with atazanavir as salvage therapy in HIV patients does not lead to a pronounced increase in plasma concentrations of lopinavir and atazanavir, according to German researchers.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Thu, 17 Jul 2008 10:52:44 EDT</pubDate>
		</item>
		<item>
			<title>Conjunctiva Carcinoma Risk Increased in HIV Patients</title>
			<link>http://www.medscape.com/viewarticle/577504?src=rss</link>
			<description>Patients infected with HIV face an increased risk of developing squamous cell carcinoma of the conjunctiva (SCCC), according to a report in the June 1st issue of the International Journal of Cancer.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Thu, 17 Jul 2008 11:57:08 EDT</pubDate>
		</item>
		<item>
			<title>Malignancies in Women With HIV Infection</title>
			<link>http://www.medscape.com/viewarticle/576808?src=rss</link>
			<description>HIV-infected women are at increased risk for certain malignancies and premalignant HPV-related changes. Screening recommendations and treatment of HIV-related cancers in women are reviewed. 
  &lt;br /&gt; &lt;i&gt;Women's Health&lt;/i&gt;</description>
			<category>Ob/Gyn and Women&apos;s Health</category>
					<pubDate>Thu, 24 Jul 2008 14:46:45 EDT</pubDate>
		</item>
		<item>
			<title>Marked Increase in the Incidence of Invasive Anal Cancer Among HIV-infected Patients Despite Treatment With Combination Antiretroviral Therapy</title>
			<link>http://www.medscape.com/viewarticle/576410?src=rss</link>
			<description>Learn why the incidence of anal cancer has increased among HIV-infected patients in France since 1996. 
  &lt;br /&gt; &lt;i&gt;AIDS&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Wed, 23 Jul 2008 16:53:53 EDT</pubDate>
		</item>
		<item>
			<title>Outcomes of Multidrug-resistant Patients Switched From Enfuvirtide to Raltegravir Within a Virologically Suppressive Regimen</title>
			<link>http://www.medscape.com/viewarticle/576411?src=rss</link>
			<description>Thirty-five adults electively replaced enfuvirtide with raltegravir while the rest of their regimen was unchanged. Did they maintain virologic suppression? 
  &lt;br /&gt; &lt;i&gt;AIDS&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Thu, 24 Jul 2008 10:21:24 EDT</pubDate>
		</item>
		<item>
			<title>Enhancing Antiretroviral Activity in the Brain</title>
			<link>http://www.medscape.com/viewarticle/577107?src=rss</link>
			<description>Can drugs with high CSF penetration treat HIV-associated neurological syndromes more effectively than others? 
  &lt;br /&gt; &lt;i&gt;AIDS Clinical Care&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Thu, 24 Jul 2008 16:26:51 EDT</pubDate>
		</item>
		<item>
			<title>Bacterial Vaginosis and Vaginal Yeast, but Not Vaginal Cleansing, Increase HIV-1 Acquisition in African Women</title>
			<link>http://www.medscape.com/viewarticle/576316?src=rss</link>
			<description>The interrelationships between bacterial vaginosis, vaginal yeast, vaginal practices (cleansing and drying/tightening), mucosal inflammation, and HIV acquisition are discussed. 
  &lt;br /&gt; &lt;i&gt;JAIDS: Journal of Acquired Immune Deficiency Syndromes&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Tue, 22 Jul 2008 10:21:14 EDT</pubDate>
		</item>
		<item>
			<title>Early Changes in T-Cell Activation Predict Antiretroviral Success in Salvage Therapy of HIV Infection</title>
			<link>http://www.medscape.com/viewarticle/576314?src=rss</link>
			<description>The early changes in immune activation associated with subsequent virologic response to therapy is discussed. 
  &lt;br /&gt; &lt;i&gt;JAIDS: Journal of Acquired Immune Deficiency Syndromes&lt;/i&gt;</description>
			<category>HIV/AIDS</category>
					<pubDate>Wed, 23 Jul 2008 11:57:02 EDT</pubDate>
		</item>

</channel>
</rss>